[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group: in addition to receiving routine national treatments for this disease, undergo intravenous injection of 100 ml of normal saline 5 times in completely similar conditions to the intervention group.", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: patients are treated by intravenous injection of 5 times supernatant culture medium of allogeneic menstrual blood-derived stem cells. After isolation and culture in a cleanroom under the GMP of Sina Biomedical Engineering Company GMP and passing and quality control tests, stem cells are stored in the cell bank. After cell thawing and culture in a GMP-approved culture medium, this surface culture medium is collected and centrifuged to remove cells and cell debris, and after filtration, quality control tests are performed on the collected culture medium. The 5 ml cell secretion is then filled into sterile vials and packaged. Each vial dissolved in 100 ml of normal saline is injected through a peripheral vein over a period of 30-60 minutes.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 598, "treatment_name": "Human menstrual blood-derived stem cells", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]